acut
respiratori
tract
infect
caus
substanti
mortal
morbid
age
apart
influenza
respiratori
syncyti
virus
rsv
sever
respiratori
virus
remain
larg
understand
defin
contribut
viral
etiolog
sever
respiratori
ill
countri
like
south
africa
high
burden
human
immunodefici
viru
hiv
infect
associ
acquir
immunodefici
syndrom
may
import
health
manag
plan
prior
south
african
studi
respiratori
specimen
patient
hospitalis
sever
acut
respiratori
ill
sari
test
neg
screen
virus
parainfluenza
viru
piv
type
rsv
enteroviru
human
metapneumoviru
hmpv
adenoviru
adv
rhinoviru
rv
influenza
infa
influenza
b
infb
respiratori
virus
includ
routin
diagnost
test
human
bocaviru
hbov
human
coronavirus
hcov
human
polyomavirus
hpyv
may
respons
viral
respiratori
ill
among
patient
test
neg
commonli
screen
virus
human
bocaviru
hpyv
hcov
infect
report
among
patient
respiratori
tract
infect
differ
virus
usual
poorli
investig
routin
surveil
diagnost
purpos
aim
assess
preval
hbov
washington
univers
human
polyomaviru
karolinska
insitut
human
polyomaviru
among
hospitalis
patient
sari
south
africa
studi
particip
enrol
prospect
sari
surveil
januari
decemb
sever
acut
respiratori
ill
surveil
conduct
sentinel
site
north
west
hospit
complex
klerksdorp
edendal
hospit
pietermaritzburg
mpumalanga
matikwana
mapulaneng
hospit
agincourt
gauteng
chri
hani
baragwanath
hospit
provinc
south
africa
sever
acut
respiratori
ill
case
defin
hospitalis
patient
symptom
onset
within
day
symptom
onset
durat
chang
day
hospit
admiss
met
inclus
criteria
includ
children
age
day
month
sepsi
acut
lower
respiratori
tract
infect
irrespect
sign
symptom
children
age
month
year
acut
lower
respiratori
tract
infect
pleural
effus
individu
age
year
physician
diagnos
lower
respiratori
tract
infect
sudden
onset
temperatur
histori
fever
cough
sore
throat
short
breath
difficulti
studi
procedur
describ
briefli
studi
staff
review
hospit
admiss
regist
identifi
patient
meet
sari
case
definit
patient
met
case
definit
approach
consent
surveil
offic
patient
consent
particip
studi
ask
complet
questionnair
interview
record
previou
medic
histori
clinic
data
consent
patient
ask
provid
respiratori
clinic
specimen
time
permiss
obtain
use
store
specimen
research
studi
consent
patient
hiv
result
obtain
medic
record
avail
time
enrol
test
spot
perform
nation
institut
communic
diseas
johannesburg
south
africa
human
immunodefici
viru
test
includ
polymeras
chain
reaction
pcr
children
age
month
immunosorb
assay
patient
age
month
nasopharyng
aspir
collect
children
age
year
combin
nasopharyng
oropharyng
swab
collect
person
age
year
specimen
place
viral
highveld
biolog
johannesburg
south
africa
univers
copan
murrieta
california
usa
transport
medium
store
within
hour
collect
specimen
transport
nation
institut
communic
diseas
johannesburg
south
africa
test
respiratori
specimen
store
sort
collect
date
subset
respiratori
specimen
randomli
select
year
age
inclus
studi
total
specimen
collect
surveil
period
everi
eighth
specimen
systemat
select
inclus
studi
obtain
studi
sampl
specimen
test
use
multiplex
revers
transcript
pcr
assay
follow
virus
hbov
assay
perform
use
paramet
cycl
condit
previous
follow
modif
dt
primer
random
hexam
primer
use
revers
transcript
reaction
respiratori
specimen
sari
surveil
also
routin
test
multiplex
assay
adv
enteroviru
hmpv
piv
type
rsv
rv
infa
preval
hbov
hcov
hpyv
virus
compar
age
group
individu
individu
without
underli
medic
condit
predominantli
asthma
heart
diseas
pregnanc
diabet
seizur
disord
malnutrit
use
test
fisher
exact
test
version
statacorp
colleg
station
texa
usa
use
implement
analysi
protocol
approv
univers
witwatersrand
univers
ethic
committe
surveil
programm
deem
nonresearch
us
center
diseas
control
prevent
nonresearch
determin
number
among
patient
includ
studi
children
age
year
account
largest
proport
case
among
individu
avail
inform
hiv
preval
preval
underli
medic
condit
count
inform
avail
limit
number
individu
therefor
result
could
util
age
distribut
hiv
preval
case
includ
exclud
studi
statist
similar
tabl
among
hbov
hcov
hpyv
hbov
frequent
detect
human
detect
specimen
tabl
preval
hbov
similar
higher
respiratori
virus
commonli
test
includ
hmpv
infa
infb
tabl
human
bocaviru
frequent
detect
among
children
age
year
signific
differ
preval
across
age
group
observ
p
fisher
exact
test
among
commonli
test
virus
age
group
hmpv
piv
infa
infb
viru
lower
preval
respect
compar
hbov
hcov
hpyv
studi
studi
specimen
test
neg
viral
target
assay
therefor
test
addit
virus
hbov
hcov
hpyv
decreas
number
specimen
initi
test
neg
human
bocaviru
commonli
detect
among
individu
howev
statist
signific
observ
individu
compar
individu
tabl
karolinska
insitut
human
polyomaviru
also
frequent
detect
among
patient
underli
medic
condit
differ
howev
statist
signific
tabl
percent
patient
infect
hbov
coinfect
virus
respect
among
coinfect
virus
rv
common
follow
adv
rsv
coinfect
infa
infb
virus
observ
detect
rate
hbov
hcov
children
age
year
like
infect
hbov
comparison
older
children
adult
overal
preval
hbov
among
patient
sari
similar
higher
commonli
detect
respiratori
virus
hmpv
piv
type
infa
infb
howev
high
coinfect
rate
observ
especi
among
infect
patient
virus
make
interpret
etiolog
associ
difficult
kept
mind
studi
would
aim
address
although
detect
hbov
specimen
test
case
hbov
mrna
viral
dna
load
assess
proport
case
activ
infect
describ
xu
et
similar
studi
conduct
south
africa
hospitalis
children
age
year
requir
medic
attent
hospit
test
sever
respiratori
virus
includ
test
among
children
hbov
detect
specimen
respect
studi
higher
preval
report
tabl
may
due
differ
case
definit
use
studi
find
similar
report
studi
conduct
gulf
region
children
year
age
latter
studi
report
detect
rate
virus
hbov
global
hbov
predominantli
observ
children
age
year
upper
lower
respiratori
tract
infect
also
observ
recent
south
african
studi
found
among
children
age
year
hbov
hcov
detect
significantli
associ
sever
human
polyomavirus
investig
latter
studi
therefor
inclus
laboratori
test
hbov
differenti
test
algorithm
surveil
diagnost
suspect
case
respiratori
ill
unknown
caus
may
improv
understand
etiolog
sari
especi
countri
like
south
africa
high
number
immun
compromis
person
studi
limit
warrant
discuss
first
patient
sari
includ
studi
control
particip
group
evalu
associ
andor
fraction
hbov
hcov
hpyv
detect
may
contribut
sever
respiratori
ill
could
investig
second
sampl
size
small
data
south
africa
lack
therefor
use
expect
preval
obtain
biggest
sampl
size
confid
interv
desir
absolut
precis
design
effect
plu
inflat
spoilagequ
sampl
annual
expect
sampl
studi
year
lastli
studi
durat
short
period
requir
assess
season
therefor
season
hbov
hcov
hpyv
determin
conclus
low
preval
hbov
similar
higher
import
virus
commonli
test
hmpv
piv
type
infa
infb
includ
test
hbov
hcov
hpyv
virus
differenti
diagnost
algorithm
surveil
routin
diagnost
may
improv
understand
viral
etiolog
sari
hospitalis
patient
high
hivaid
burden
countri
like
south
africa
howev
associ
viru
detect
sever
respiratori
ill
investig
present
south
africa
order
maintain
sustain
respiratori
ill
surveil
programm
expand
test
viral
etiolog
mainli
conduct
patient
sari
includ
death
intens
care
unit
admiss
unknown
caus
outbreak
investig
special
diagnost
test
request
identif
etiolog
agent
desir
possibl
public
health
action
work
support
nation
institut
communic
diseas
nation
health
laboratori
servic
center
diseas
control
prevent
cooper
agreement
conflict
interest
declar
coauthor
conceptu
marietji
venter
orienka
hellfersce
marthi
pretoriu
cheryl
cohen
florett
k
treurnicht
data
curat
kathleen
subramoney
orienka
hellfersce
stefano
tempia
meredith
mcmorrow
ann
von
gottberg
formal
analysi
kathleen
subramoney
orienka
hellfersce
stefano
tempia
meredith
mcmorrow
ann
von
gottberg
investig
marietji
venter
orienka
hellfersce
marthi
pretoriu
cheryl
cohen
florett
k
treurnicht
methodolog
orienka
hellfersce
marthi
pretoriu
ann
von
gottberg
nicol
wolter
ebrahim
variava
halima
dawood
kathleen
kahn
sibongil
walaza
cheryl
cohen
marietji
venter
florett
k
treurnicht
resourc
orienka
hellfersce
marthi
pretoriu
ann
von
gottberg
nicol
wolter
ebrahim
variava
halima
dawood
kathleen
kahn
sibongil
walaza
cheryl
cohen
marietji
venter
florett
k
treurnicht
softwar
kathleen
subramoney
orienka
hellfersce
marthi
pretoriu
stefano
tempia
meredith
mcmorrow
nicol
wolter
sibongil
walaza
draft
prepar
kathleen
subramoney
orienka
hellfersce
florett
k
treurnicht
edit
kathleen
subramoney
orienka
hellfersce
marthi
pretoriu
stefano
tempia
meredith
mcmorrow
ann
von
gottberg
nicol
wolter
sibongil
walaza
shabir
madhi
cheryl
cohen
florett
k
treurnicht
marietji
venter
find
conclus
report
author
necessarili
repres
offici
posit
center
diseas
control
prevent
